Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Gentamicin for Prevention of PD-Related Infection
NCT05251584Unknown
- Sponsor
- Phramongkutklao College of Medicine and Hospital
- Start
- Dec 2021
- Primary completion
- Mar 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Open-label, single-arm trial of gentamicin in peritoneal dialysis-related peritonitis, sponsored by Phramongkutklao College of Medicine and Hospital. Primary endpoints: Rate of Exit-site infection at 1 year and Rate of Infectious peritonitis at 1 year. Status: unknown.
02
Drugs
gentamicin
03
Conditions
peritoneal dialysis-related peritonitis
Beyond the preview
Go deeper on NCT05251584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05251584.